EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Systematic Multiplatform Discovery of Methylation Markers Enables Non‐Invasive Early Detection of Endometrial Cancer

Yan Cai, Shuchao Chen, Zhen Wu, Jinxia Guan, Jie Zhao iD, Jianwei Ye, Baochen Du, Xiaoliang Han, Tong Shu, Guangpeng Zhou, Hong Zheng

Cancer Science · 2026-05 · 117 (5) · 1412-1421

DOI: 10.1111/cas.70346 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, online erschienen am 07.03.2026. Verfasst von Yan Cai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gynecologic Oncology, Peking University Ca…. Hauptthemen laut MEDLINE: Endometrial Neoplasms, DNA Methylation, Early Detection of Cancer, Biomarkers, Tumor. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Clinical Research Fund For Distinguished Young Scholars of Peking University Cancer Hospital..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endometrial cancer, the most common gynecological malignancy with an annual increase of 1%–3%, lacks suitable noninvasive diagnostic tools, as current methods like hysteroscopy and biopsy are invasive and impractical for routine screening. We conducted a comprehensive, multilayered marker discovery workflow integrating whole‐genome bisulfite sequencing and targeted methylation panels in tumor and control tissues, then prioritized and optimized candidates for detection in cervical exfoliated cells. Using a two‐stage design, we built and tested a quantitative methylation–specific PCR (qMSP) model in ThinPrep Cytology Test (TCT) samples, with 148 samples for discovery/model construction and an independent cohort of 80 TCT samples for validation. We identified a three‐gene methylation panel—ZNF626, GRIA4, and SPDYA—that demonstrated high accuracy for early endometrial cancer detection from cervical cytology. In the validation cohort, the model showed strong performance across menopausal subgroups: in premenopausal women, sensitivity was 90.91% and specificity for benign endometrial disease was 92.59%; in postmenopausal women, sensitivity and specificity were 96.55% and 84.62%, respectively. Notably, the approach achieved a 92.86% detection rate for stage I endometrial cancer. These results support a robust, noninvasive diagnostic strategy that leverages simple cervical cytology sampling to enable early detection, facilitate clinical decision‐making, and potentially improve outcomes for patients at risk of endometrial cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsDNA MethylationEarly Detection of CancerBiomarkers, TumorHumansFemaleMiddle AgedAdultSensitivity and SpecificityAged

Stichwörter der Autor:innen

DNA methylationEC diagnostic modelTCT sampleearly detectionendometrial cancer

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gynecologic Oncology, Peking University Cancer Hospital & Institute, Beijing, China.
  • BioChain (Beijing) Science & Technology Inc., Beijing, China.

ORCID-Profile: Jie Zhao

Förderung

  • Clinical Research Fund For Distinguished Young Scholars of Peking University Cancer Hospital.

Zitieren

APA

Cai, Y., Chen, S., Wu, Z., Guan, J., Zhao, J., Ye, J., Du, B., Han, X., Shu, T., Zhou, G., & Zheng, H. (2026). Systematic Multiplatform Discovery of Methylation Markers Enables Non‐Invasive Early Detection of Endometrial Cancer. Cancer Science, 117(5), 1412-1421. https://doi.org/10.1111/cas.70346

Vancouver

Cai Y, Chen S, Wu Z, Guan J, Zhao J, Ye J, et al. Systematic Multiplatform Discovery of Methylation Markers Enables Non‐Invasive Early Detection of Endometrial Cancer. Cancer Science. 2026;117(5):1412-1421. doi:10.1111/cas.70346

BibTeX
@article{Cai2026,
  author = {Cai, Yan and Chen, Shuchao and Wu, Zhen and Guan, Jinxia and Zhao, Jie and Ye, Jianwei and Du, Baochen and Han, Xiaoliang and Shu, Tong and Zhou, Guangpeng and Zheng, Hong},
  title = {Systematic Multiplatform Discovery of Methylation Markers Enables Non‐Invasive Early Detection of Endometrial Cancer},
  journal = {Cancer Science},
  year = {2026},
  volume = {117},
  number = {5},
  pages = {1412--1421},
  doi = {10.1111/cas.70346}
}
Kostenlos starten →